Mydicar: Completed Phase IIb enrollment

Celladon completed enrollment of 250 patients with NYHA class III/IV symptoms of heart failure in the double-blind, placebo-controlled, international Phase IIb CUPID 2 trial evaluating a single intracoronary infusion of Mydicar. Celladon has received scientific advice from EMA for CUPID 2. ...